Provided by Tiger Trade Technology Pte. Ltd.

Corvus Pharmaceuticals

16.06
-1.7800-9.98%
Post-market: 16.380.3200+1.99%19:48 EST
Volume:1.28M
Turnover:20.91M
Market Cap:1.35B
PE:-28.75
High:17.60
Open:17.40
Low:15.90
Close:17.84
52wk High:26.95
52wk Low:2.54
Shares:83.77M
Float Shares:67.20M
Volume Ratio:1.47
T/O Rate:1.90%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.5587
EPS(LYR):-1.0214
ROE:-35.82%
ROA:-34.87%
PB:18.75
PE(LYR):-15.72

Loading ...

Corvus Pharmaceuticals Inc. Updates Financial Calendar

Reuters
·
5 hours ago

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Yesterday

Corvus Pharmaceuticals options imply 5.5% move in share price post-earnings

TIPRANKS
·
Yesterday

Does Corvus Pharmaceuticals’ (CRVS) Soquelitinib Focus Clarify Its Core Strategy or Concentration Risk?

Simply Wall St.
·
Mar 02

Corvus Pharmaceuticals to Present Corporate Overview at Oppenheimer 36th Annual Healthcare Life Sciences Conference

Reuters
·
Feb 24

Corvus Pharmaceuticals (CRVS) Valuation Check After A Sharp Biotech Share Price Surge

Simply Wall St.
·
Feb 09

Assessing Corvus Pharmaceuticals (CRVS) Valuation After Recent Share Price Momentum

Simply Wall St.
·
Feb 01

Mizuho Raises Price Target on Corvus Pharmaceuticals to $30 From $20, Keeps Outperform Rating

MT Newswires Live
·
Jan 29

Corvus Pharmaceuticals Inc : Mizuho Raises Target Price to $30 From $20

THOMSON REUTERS
·
Jan 29

Analysts Offer Insights on Healthcare Companies: Corvus Pharmaceuticals (CRVS), Elevance Health (ELV) and Universal Health (UHS)

TIPRANKS
·
Jan 29

Corvus Pharmaceuticals Down Over 10%, on Pace for Largest Percent Decrease Since March 2025 -- Data Talk

Dow Jones
·
Jan 27

Press Release: Corvus Pharmaceuticals Announces Closing of Upsized Public Offering of Common Stock and Full Exercise of the Underwriters' Option to Purchase Additional Shares, Generating Gross Proceeds of Approximately $201M

Dow Jones
·
Jan 24

Corvus Pharmaceuticals Inc : Jefferies Raises Target Price to $42 From $13

THOMSON REUTERS
·
Jan 23

Corvus Pharmaceuticals Is Maintained at Buy by Jefferies

Dow Jones
·
Jan 23

BUZZ-U.S. STOCKS ON THE MOVE-Tesla, JPMorgan, Intel

Reuters
·
Jan 23

Corvus Pharmaceuticals price target raised to $42 from $13 at Jefferies

TIPRANKS
·
Jan 23

BUZZ-U.S. STOCKS ON THE MOVE- Medicus Pharma, Lam Research, Applied Digital

Reuters
·
Jan 22

BUZZ-U.S. STOCKS ON THE MOVE-Micron, Rambus, GE Aerospace

Reuters
·
Jan 22

Press Release: Corvus Pharmaceuticals Announces Pricing of Upsized Public Offering of Common Stock

Dow Jones
·
Jan 22

Corvus Pharmaceuticals Is Maintained at Outperform by Oppenheimer

Dow Jones
·
Jan 22